Cargando…
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 pneumonia patient case with high mortality risk fac...
Autores principales: | Sodani, Pietro, Mucci, Luciano, Girolimetti, Rita, Tedesco, Silvia, Monaco, Francesca, Campanozzi, Daniele, Brunori, Marino, Maltoni, Stefania, Bedetta, Samuele, Di Carlo, Anna M., Candoli, Piero, Mancini, Mauro, Rebonato, Alberto, D'Adamo, Francesca, Capalbo, Maria, Frausini, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320265/ https://www.ncbi.nlm.nih.gov/pubmed/32670785 http://dx.doi.org/10.1016/j.rmcr.2020.101115 |
Ejemplares similares
-
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
por: Mattioli, Massimo, et al.
Publicado: (2020) -
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020) -
Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021) -
REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022) -
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)